ketoconazole has been researched along with Hearing Loss in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hazen, PG | 1 |
| Walker, AE | 1 |
| Stewart, JJ | 1 |
| Carney, JF | 1 |
| Engstrom, CW | 1 |
| Turgeon, KL | 1 |
1 other study available for ketoconazole and Hearing Loss
| Article | Year |
|---|---|
Keratitis, ichthyosis, and deafness (KID) syndrome: management with chronic oral ketoconazole therapy.
Topics: Administration, Oral; Adult; Candidiasis, Cutaneous; Carcinoma, Squamous Cell; Female; Foot Diseases | 1992 |